Tripletail Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
800
-12
-1% -$4.11K 0.34% 62
2026
Q1
$283K Sell
812
-16
-2% -$5.7K 0.39% 54
2025
Q4
$271K Sell
828
-22
-3% -$6.98K 0.34% 54
2025
Q3
$249K Hold
850
– – 0.29% 58
2025
Q2
$243K Buy
+850
New +$241K 0.35% 60

Other funds holding AMGN

Tripletail Wealth Management's AMGN Position: Q2 2026 in Review

Tripletail Wealth Management reduced its Amgen (AMGN) stake by 1.5% in Q2 2026, selling an estimated $4.11K and leaving 800 shares worth $299K. The position accounts for 0.34% of the portfolio, ranked #62.

Tripletail Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tripletail Wealth Management held 800 shares of Amgen worth $299K as of Q2 2026.
  • Tripletail Wealth Management sold 12 Amgen shares in Q2 2026, an estimated $4.11K.
  • Amgen made up 0.34% of Tripletail Wealth Management's portfolio in Q2 2026, its #62 holding.
  • Tripletail Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.